{
    "clinical_study": {
        "@rank": "53710", 
        "acronym": "CATS", 
        "arm_group": [
            {
                "arm_group_label": "Intervention", 
                "arm_group_type": "Experimental", 
                "description": "The anxiety risk reduction condition will be a combination of psychoeducation plus Cognitive Bias Modification (CBM-I) for anxiety sensitivity (AS). The psychoeducational component will focus on the nature of stress and its effect on the body. Interoceptive exposure (IE) exercises, designed to correct the conditioned fear to these bodily sensations, will be explained and practiced."
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "The control condition will be a combination of information about general health and wellness (e.g. diet, exercise etc.) plus an inert Cognitive Bias Modification (CBM-I) task."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to test the effectiveness and usability of multiple\n      computer-based treatments for mood and anxiety relevant risk factors. The target of the\n      treatment is related to cognitive stress, which has been shown to be associated with a\n      variety of negative mental health outcomes such as Post-Traumatic Stress Disorder, suicidal\n      ideation, and substance use disorders."
        }, 
        "brief_title": "Computerized Anxiety Treatment for Suicide", 
        "completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Anxiety", 
            "Suicide"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Anxiety Disorders", 
                "Suicide"
            ]
        }, 
        "detailed_description": {
            "textblock": "CATS is a newly developed computerized treatment targeting specific risk factors associated\n      with anxiety symptoms and suicidal thoughts. Individuals will be asked to complete four\n      appointments, where they will complete various self-report questionnaires as well as a newly\n      developed computerized treatment targeting risk factors associated with anxiety."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Meet diagnostic criteria for a primary Axis 1 anxiety disorder or meet diagnostic\n             criteria for a unipolar mood disorder along with an Axis 1 anxiety disorder.\n\n          -  Show evidence of current suicidal ideation (BSS above 6.\n\n          -  Show elevated AS indicated by scoring at or above the community sample mean on the\n             ASI-Cog (above 9.\n\n        Exclusion Criteria:\n\n          -  No significant medical illness (e.g. sig cardiovascular disease, epilepsy, stroke).\n\n          -  Current or past psychotic-spectrum disorders or uncontrolled bipolar disorder\n\n          -  No current substance dependence\n\n          -  Must be an English speaker.\n\n          -  Must be 18 years or older.\n\n          -  Must have normal or corrected vision\n\n          -  Cannot begin treatment/therapy within 1 month of baseline.\n\n          -  Cannot begin a new medication within 3 months of baseline."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "74", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01990131", 
            "org_study_id": "RF02397"
        }, 
        "intervention": [
            {
                "arm_group_label": "Intervention", 
                "intervention_name": "Cognitive Anxiety Sensitivity Treatment", 
                "intervention_type": "Other", 
                "other_name": "Computerized Anxiety Treatment for Suicide (CATS)"
            }, 
            {
                "arm_group_label": "Control", 
                "intervention_name": "Physical Health Education Training", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "computerized intervention", 
            "cognitive bias modification", 
            "anxiety", 
            "suicide"
        ], 
        "lastchanged_date": "November 20, 2013", 
        "location": {
            "contact": {
                "email": "abhcfsu@psy.fsu.edu", 
                "last_name": "Norman B Schmidt, Ph.D.", 
                "phone": "850-645-1766"
            }, 
            "facility": {
                "address": {
                    "city": "Tallahassee", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "32304"
                }, 
                "name": "Anxiety and Behavioral Health Clinic"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Suicide Risk Prevention Among Patients With Anxiety Psychopathology", 
        "overall_contact": {
            "email": "abhcfsu@psy.fsu.edu", 
            "last_name": "Norman B Schmidt, Ph.D.", 
            "phone": "(850) 645-1766"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The ASI-3 is an 18-item self-report measure of anxiety sensitivity (AS). This scale was developed to provide a more stable measure of the three most widely recognized AS subfactors (cognitive, social and physical concerns) than the original ASI provides. Each subfactor is represented by six items. The measure has shown good psychometric properties.", 
            "measure": "Anxiety Sensitivity Index-3 (ASI-3)", 
            "safety_issue": "No", 
            "time_frame": "Month 4 follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01990131"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Florida State University", 
            "investigator_full_name": "Norman Schmidt", 
            "investigator_title": "Distinguished Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The BSS is a 21-item widely used self-report measure assessing a broad spectrum of behaviors and attitudes related to suicide risk, including suicidal ideation and past suicide attempts. It has demonstrated strong reliability and validity.", 
            "measure": "Beck Suicide Scale (BSS)", 
            "safety_issue": "Yes", 
            "time_frame": "Month 4 follow-up"
        }, 
        "source": "Florida State University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Florida State University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}